To analyze syntenic genomic regions for overlapping CNAs, we applied two statistical frameworks to BRCA1-deficient, BRCA2-deficient and BRCA1/2-proficient control mouse and human breast cancers: a total of six tumor groups. This evidence concerns the gene BRCA2 and neoplasm.